A 70-year-old man with ischaemic heart disease and diabetes asks about aspirin for primary prevention of cardiovascular events. His 5-year CVD risk is 12% but he has had no prior MI or stroke. According to current Australian CVD guidelines, what is the recommendation for aspirin in primary prevention?